Adi F. Gazdar

Weatherford College — United States

Medicine · Health Sciences

161h-index114.6kcitations1.2kworks0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(318), RNA modifications and cancer(230), Lung Cancer Research Studies(172), Epigenetics and DNA Methylation(141), Cancer Genomics and Diagnostics(121)

Publications1.2k total

Editor’s Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Cancer Research·2025Open Access

ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers

3 cited

2023· 3 citedOpen Access

Supplementary Figure Legends 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Figures S1-S16 from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition

2023Open Access

Tables S1-S5 from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition

2023Open Access

Supplementary Figures 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Supplementary Tables 1-2 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Figures S1-S16 from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition

2023Open Access

Supplementary Tables 1-2 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Data from Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations

2023Open Access

Supplementary Methods, Tables 1 - 4, Figures 1 - 7 from Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations

2023Open Access

Supplementary Methods from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Tables S1-S5 from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition

2023Open Access

Data from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Supplementary Figures 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Supplementary Methods from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Data from Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations

2023Open Access

Data from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

Data from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition

2023Open Access

Supplementary Figure Legends 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

2023Open Access

page 1 of 63Next →

Frequent Co-authors

John D. Minna(26), Luc Girard(7), Paul A. Bunn(5), Ignacio I. Wistuba(5), Kwun M. Fong(5), Roman K. Thomas(5), Valerie W. Rusch(4), Hisayuki Shigematsu(4), Shinichi Toyooka(4), Marion M. Nau(4), Matthew Meyerson(4), David G. Beer(3), Ming‐Sound Tsao(3), Jack A. Roth(3), J D Minna(3), William Pao(3), Jane E. Johnson(3), Barbara A. Weir(3), Rameen Beroukhim(3), Levi A. Garraway(3)